Ovary Cancer Clinical Trials

56 clinical trials for Ovary Cancer across international registries, including 18 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib — RECRUITING · PHASE2
• An Exploratory Study on the Use of Ipalotinib (Tislelizumab) Combined With Sunitinib and Olaparib for Neoadjuvant Therapy in HRD-positive Advanced Ovarian Cancer — RECRUITING · PHASE2
• A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression — RECRUITING · PHASE1
• Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) — RECRUITING
• Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) — RECRUITING · NA
• Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy — RECRUITING · NA
• Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy — RECRUITING · PHASE2
• Multimedia Aid for Genetic Testing in Gynecologic Oncology — RECRUITING · NA
• Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer — RECRUITING · PHASE2
• No-Stoma Policy in Advanced Ovarian Cancer Surgery — RECRUITING · NA
• Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers — RECRUITING · PHASE1
• RC48 in Combination With AK104 and Bevacizumab in OCCC — RECRUITING · PHASE2
• Mesenteric Infiltration in Ovarian Cancer — RECRUITING
• Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study — RECRUITING
• The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women — RECRUITING · NA
• Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors — RECRUITING · PHASE1
• Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker — RECRUITING
• Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer — RECRUITING · PHASE2
• Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological Malignancies — NOT_YET_RECRUITING
• Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines — WITHDRAWN · PHASE1
• INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study — NOT_YET_RECRUITING · NA
• Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health — COMPLETED · NA
• GYNecologic Cancer-Related COGnitive Impairment — COMPLETED · NA
• Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention — ACTIVE_NOT_RECRUITING · NA
• NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors — TERMINATED · PHASE1
• Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK — COMPLETED
• A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer — TERMINATED · PHASE1
• Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers — COMPLETED · PHASE1
• An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies — COMPLETED · PHASE1
• ICRA Randomised Controlled Trial — NOT_YET_RECRUITING · PHASE3
• KORE-INNOVATION: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients with Ovarian Cancer — COMPLETED · NA
• Oral AMXT 1501 Dicaprate in Combination With IV DFMO — TERMINATED · PHASE1
• ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) — TERMINATED · PHASE1
• Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors — OTHER · PHASE1
• SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours — NOT_YET_RECRUITING
• Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy — COMPLETED · NA
• A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer — WITHDRAWN · PHASE1
• Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery — COMPLETED · PHASE3
• Gynaecology Exercise and Mindfulness Study — OTHER · NA
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors — COMPLETED · PHASE1
• Effects of Music or Hypnotherapy on Cancer Patients During Chemotherapy — TERMINATED · NA
• Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. — COMPLETED · PHASE2
• The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib — OTHER
• Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1 — OTHER
• Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer — OTHER · NA
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors — COMPLETED · PHASE1
• Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy — COMPLETED
• The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer — TERMINATED · PHASE1

Refine this search